Efficacy & Safety of B244: A Live Topical Biotherapeutic, in Patients with Mild to Moderate Atopic Dermatitis & Associated Pruritus

Time: 9:00 am
day: Day One


  • Introducing B244, an ammonia oxidizing bacteria, as a topical spray investigational product
  • Efficacy of B244 in itch relief and lesion control from a 547 patient Phase 2b study in mild to moderate atopic dermatitis
  • Safety profile of B244